Presentation TVT 2017 Is Para-valvular Regurgitation After TAVR Still an Important Consideration in 2017? Presenter: Philippe Pibarot June 15, 2017
Presentation TVT 2017 A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR Presenter: Mark J. Russo June 15, 2017
Presentation TVT 2017 Setting the Stage: Achieving Acceptance for TAVR in All Patients With Severe AS Presenter: Martin B. Leon June 15, 2017
Presentation TVT 2017 The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico) Presenter: Danny Dvir June 15, 2017
Presentation TVT 2017 Optimizing Outcomes of Valve-in-Valve TAVR: The Role of Bioprosthetic Valve Fracture Presenter: David J. Cohen June 15, 2017
Presentation TVT 2017 Case Presentation: A Case of Valve-in-Valve TAVR in a Stentless Bioprosthesis Presenter: Molly Szerlip June 15, 2017
Presentation TVT 2017 A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection Presenter: Jochen Wöhrle June 15, 2017
Presentation TVT 2017 The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC Presenter: Alexandra J. Lansky June 15, 2017
Presentation TVT 2017 TAVR in Perspective Evolution, Impact, and Future Expectations Presenter: Martin B. Leon June 15, 2017
Presentation TVT 2017 Featured Lecture: The Use of TAVR for Bioprosthetic Aortic Valve Failure - Only for High-Risk Surgical Patients or an Integral Component of AS Management Strategies Presenter: Thomas Walther June 15, 2017